AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-11.8%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$5.73M
AUM Growth
+$5.73M
(-100%)
Cap. Flow
-$632M
Cap. Flow
% of AUM
-11,034.11%
Top 10 Holdings %
Top 10 Hldgs %
49.82%
Holding
215
New
76
Increased
44
Reduced
24
Closed
39
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$1.26M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$567K |
| 3 |
O'Reilly Automotive
ORLY
|
$92K |
| 4 |
Dollar General
DG
|
$75.6K |
| 5 |
Neurocrine Biosciences
NBIX
|
$65.7K |
Top Sells
| 1 |
Home Depot
HD
|
$105M |
| 2 |
Target
TGT
|
$68.3M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$62.1M |
| 4 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
$62M |
| 5 |
Five Below
FIVE
|
$57.3M |
Sector Composition
| 1 | Healthcare | 44.4% |
| 2 | Consumer Staples | 8.91% |
| 3 | Consumer Discretionary | 7.35% |
| 4 | Technology | 4.07% |
| 5 | Communication Services | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.26M | 22.05% | +33,500 | New | +$1.26M |
|
|
2
iShares Russell 2000 ETF
IWM
$67B
| $567K | 9.9% | +33,500 | New | +$567K |
|
3
Incyte
INCY
$16.5B
| $152K | 2.65% | 2,000,000 +476,000 | +31% | +$36.2K |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $137K | 2.4% | 2,048,000 +684,000 | +50% | +$45.9K |
|
5
Supernus Pharmaceuticals
SUPN
$2.53B
| $136K | 2.38% | 4,712,000 +1,612,000 | +52% | +$46.6K |
|
6
PTC Therapeutics
PTCT
$3.92B
| $132K | 2.3% | 3,296,000 +260,000 | +9% | +$10.4K |
|
|
7
Neurocrine Biosciences
NBIX
$13.8B
| $129K | 2.25% | 1,324,000 +674,000 | +104% | +$65.7K |
|
8
Travere Therapeutics
TVTX
$1.56B
| $129K | 2.25% | 5,320,000 +362,000 | +7% | +$8.77K |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $111K | 1.94% | 188,000 +104,000 | +124% | +$61.5K |
|
10
Enanta Pharmaceuticals
ENTA
$180M
| $97.8K | 1.71% | 2,070,000 +946,000 | +84% | +$44.7K |
|
|
11
O'Reilly Automotive
ORLY
$88B
| $92K | 1.6% | +145,581 | New | +$92K |
|
12
Bristol-Myers Squibb
BMY
$96B
| $89K | 1.55% | 1,156,000 -240,000 | -17% | -$18.5K |
|
13
Vertex Pharmaceuticals
VRTX
$100B
| $87.9K | 1.53% | 312,000 +76,000 | +32% | +$21.4K |
|
14
Alkermes
ALKS
$4.78B
| $87.1K | 1.52% | 2,924,000 +1,100,000 | +60% | +$32.8K |
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $78.7K | 1.37% | 1,100,000 +122,000 | +12% | +$8.73K |
|
|
16
Dollar General
DG
$23.9B
| $75.6K | 1.32% | +308,143 | New | +$75.6K |
|
17
Medtronic
MDT
$119B
| $71.8K | 1.25% | 800,000 +332,000 | +71% | +$29.8K |
|
18
Catalyst Pharmaceutical
CPRX
$2.52B
| $71.5K | 1.25% | 10,200,000 +1,828,000 | +22% | +$12.8K |
|
19
argenx
ARGX
$43.6B
| $71.2K | 1.24% | 188,000 -12,000 | -6% | -$4.55K |
|
|
DCPH
20
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $71K | 1.24% | 5,400,000 -436,000 | -7% | -$5.73K |
|
21
Central Garden & Pet Class A
CENTA
$2.08B
| $65K | 1.13% | 1,624,000 +88,000 | +6% | +$3.52K |
|
22
Illumina
ILMN
$15.8B
| $62.5K | 1.09% | 339,000 +161,000 | +90% | +$29.7K |
|
23
lululemon athletica
LULU
$24.2B
| $62.3K | 1.09% | +228,573 | New | +$62.3K |
|
24
AB InBev
BUD
$122B
| $61.3K | 1.07% | 1,136,000 +158,000 | +16% | +$8.52K |
|
25
CRISPR Therapeutics
CRSP
$4.71B
| $60.8K | 1.06% | 1,000,000 -24,000 | -2% | -$1.46K |
|